• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:吾红光,赵依侬,郑小平,徐燕飞,阎杭丽.复方乳酸杆菌治疗幽门螺杆菌临床疗效观察[J].中国现代应用药学,2009,(9):776-778.
WU Hongguang, ZHAO Yinong, ZHENG Xiaoping, XU Yanfei, YAN Hangli.Observation on Clinical Effect of Compound Lactobacillus in Treatment of Helicobacter Pylori[J].Chin J Mod Appl Pharm(中国现代应用药学),2009,(9):776-778.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2122次   下载 1304 本文二维码信息
码上扫一扫!
分享到: 微信 更多
复方乳酸杆菌治疗幽门螺杆菌临床疗效观察
吾红光,赵依侬,郑小平,徐燕飞,阎杭丽
作者单位
吾红光,赵依侬,郑小平,徐燕飞,阎杭丽  
摘要:
目的探讨用微生物制剂治疗幽门螺旋杆菌(HP)的效果。方法选取我院检测幽门螺旋杆菌阳性病人160例,随机分成两组。治疗组用复方乳酸杆菌联合替普瑞酮治疗一个月。对照组用常规质子泵抑制剂(PPI)方案治疗7 d。疗程结束后分别行胃镜病理活检及14C呼气试验检测HP,比较两组治疗方案的HP根除率。结果治疗组根除率87.75%,对照组根除率76.92%,两组比较差异无显著性,P>0.05。结论微生物制剂治疗幽门螺旋杆菌感染方面的作用与抗菌药相似,可进一步扩大总结与应用。
关键词:  复方乳酸杆菌  幽门螺旋杆菌  质子泵抑制剂
DOI:
分类号:
基金项目:
Observation on Clinical Effect of Compound Lactobacillus in Treatment of Helicobacter Pylori
WU Hongguang, ZHAO Yinong, ZHENG Xiaoping, XU Yanfei, YAN Hangli
Abstract:
OBJECTIVE To investigate the efficacy of microbiological preparation in helicobacter pylori therapy. METHODS 160 helicobacter pylori (HP)-positive patients were randomly divided into the compound lactobacillus group (compound lactobacillus and teprenone for one month) and PPI group(PPI for 7 d). After treatment, endoscopic mucosal resection and 14C-urea breath test were used to compare HP eradication rate of the two groups. RESULTS The eradication rate of compound lactobacillus group and control were 87.75% and 76.92%, with no statistical difference (P>0.05). CONCLUSION Our results suggest that microbiological preparation is similar to antibacterial in helicobacter pylori infection therapy, deserving further application.
Key words:  compound lactobacillus  helicobacter pylori  proton pump inhibitor
扫一扫关注本刊微信